Unknown

Dataset Information

0

Gelatin Nanoparticle-Coated Silicon Beads for Density-Selective Capture and Release of Heterogeneous Circulating Tumor Cells with High Purity.


ABSTRACT: Background: Circulating tumor cells (CTCs) are a burgeoning topic in cancer biomarker discovery research with minimal invasive blood draws. CTCs can be used as potential biomarkers for disease prognosis, early cancer diagnosis and pharmacodynamics. However, the extremely low abundance of CTCs limits their clinical utility because of technical challenges such as the isolation and subsequent detailed molecular and functional characterization of rare CTCs from patient blood samples. Methods: In this study, we present a novel density gradient centrifugation method employing biodegradable gelatin nanoparticles coated on silicon beads for the isolation, release, and downstream analysis of CTCs from colorectal and breast cancer patients. Results: Using clinical patient/spiked samples, we demonstrate that this method has significant CTC-capture efficiency (>80%) and purity (>85%), high CTC release efficiency (94%) and viability (92.5%). We also demonstrate the unparalleled robustness of our method in downstream CTC analyses such as the detection of PIK3CA mutations. Conclusion: The efficiency and versatility of the multifunctional density microbeads approach provides new opportunities for personalized cancer diagnostics and treatments.

SUBMITTER: Huang Q 

PROVIDER: S-EPMC5858171 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

Gelatin Nanoparticle-Coated Silicon Beads for Density-Selective Capture and Release of Heterogeneous Circulating Tumor Cells with High Purity.

Huang Qinqin Q   Wang Fu-Bing FB   Yuan Chun-Hui CH   He Zhaobo Z   Rao Lang L   Cai Bo B   Chen Bolei B   Jiang Susu S   Li Zhiqiang Z   Chen Jincao J   Liu Wei W   Guo Feng F   Ao Zheng Z   Chen Shi S   Zhao Xing-Zhong XZ  

Theranostics 20180207 6


<b>Background:</b> Circulating tumor cells (CTCs) are a burgeoning topic in cancer biomarker discovery research with minimal invasive blood draws. CTCs can be used as potential biomarkers for disease prognosis, early cancer diagnosis and pharmacodynamics. However, the extremely low abundance of CTCs limits their clinical utility because of technical challenges such as the isolation and subsequent detailed molecular and functional characterization of rare CTCs from patient blood samples. <b>Metho  ...[more]

Similar Datasets

| S-EPMC3786692 | biostudies-literature
| S-EPMC6307685 | biostudies-literature
| S-EPMC7560142 | biostudies-literature
| S-EPMC7306021 | biostudies-literature
| S-EPMC8491572 | biostudies-literature
| S-EPMC5507187 | biostudies-literature
| S-EPMC4865946 | biostudies-literature
| S-EPMC4827098 | biostudies-literature
| S-EPMC5293663 | biostudies-literature
| S-EPMC7365311 | biostudies-literature